ID   MK11_HUMAN              Reviewed;         364 AA.
AC   Q15759; B0LPG1; O00284; O15472; Q2XNF2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   02-NOV-2010, entry version 121.
DE   RecName: Full=Mitogen-activated protein kinase 11;
DE            Short=MAP kinase 11;
DE            Short=MAPK 11;
DE            EC=2.7.11.24;
DE   AltName: Full=Mitogen-activated protein kinase p38 beta;
DE            Short=MAP kinase p38 beta;
DE            Short=p38b;
DE   AltName: Full=Stress-activated protein kinase 2;
DE   AltName: Full=p38-2;
GN   Name=MAPK11; Synonyms=PRKM11, SAPK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   MEDLINE=96279333; PubMed=8663524; DOI=10.1074/jbc.271.30.17920;
RA   Jiang Y., Chen C., Li Z., Guo W., Gegner J.A., Lin S., Han J.;
RT   "Characterization of the structure and function of a new mitogen-
RT   activated protein kinase (p38beta).";
RL   J. Biol. Chem. 271:17920-17926(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Jiang Y., Han J.;
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=97350815; PubMed=9207191; DOI=10.1006/bbrc.1997.6849;
RA   Kumar S., McDonnell P.C., Gum R.J., Hand A.T., Lee J.C., Young P.R.;
RT   "Novel homologues of CSBP/p38 MAP kinase: activation, substrate
RT   specificity and sensitivity to inhibition by pyridinyl imidazoles.";
RL   Biochem. Biophys. Res. Commun. 235:533-538(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=98104165; PubMed=9430721; DOI=10.1074/jbc.273.3.1741;
RA   Enslen H., Raingeaud J., Davis R.J.;
RT   "Selective activation of p38 mitogen-activated protein (MAP) kinase
RT   isoforms by the MAP kinase kinases MKK3 and MKK6.";
RL   J. Biol. Chem. 273:1741-1748(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=97361837; PubMed=9218798; DOI=10.1093/emboj/16.12.3563;
RA   Goedert M., Cuenda A., Craxton M., Jakes R., Cohen P.;
RT   "Activation of the novel stress-activated protein kinase SAPK4 by
RT   cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison
RT   of its substrate specificity with that of other SAP kinases.";
RL   EMBO J. 16:3563-3571(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=97382284; PubMed=9235954; DOI=10.1074/jbc.272.31.19509;
RA   Stein B., Yang M.X., Young D.B., Janknecht R., Hunter T., Murray B.W.,
RA   Barbosa M.S.;
RT   "p38-2, a novel mitogen-activated protein kinase with distinct
RT   properties.";
RL   J. Biol. Chem. 272:19509-19517(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-275.
RG   NIEHS SNPs program;
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=20057165; PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-182, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-182, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-221 AND HIS-275.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Kinase involved in a signal transduction pathway that is
CC       activated by changes in the osmolarity of the extracellular
CC       environment, by cytokines, or by environmental stress.
CC       Phosphorylates preferentially transcription factor ATF2.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium (By similarity).
CC   -!- ENZYME REGULATION: Activated by phosphorylation on threonine and
CC       tyrosine by MKK6. Inhibited by pyridinyl-imidazole related
CC       compounds.
CC   -!- INTERACTION:
CC       P15336:ATF2; NbExp=1; IntAct=EBI-298304, EBI-1170906;
CC       P04637:TP53; NbExp=2; IntAct=EBI-298304, EBI-366083;
CC   -!- TISSUE SPECIFICITY: Highest levels in the brain and heart. Also
CC       expressed in the placenta, lung, liver, skeletal muscle, kidney
CC       and pancreas.
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-180 and Tyr-182, which activates
CC       the enzyme (Probable).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MAP kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/mapk11/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U53442; AAB05036.1; -; mRNA.
DR   EMBL; AF001008; AAC51250.1; -; mRNA.
DR   EMBL; AF001174; AAC51373.1; -; mRNA.
DR   EMBL; AF031135; AAC12714.1; -; mRNA.
DR   EMBL; Y14440; CAA74792.1; -; mRNA.
DR   EMBL; U92268; AAB66313.1; -; mRNA.
DR   EMBL; CR456514; CAG30400.1; -; mRNA.
DR   EMBL; DQ279722; ABB72677.1; -; Genomic_DNA.
DR   EMBL; EU332851; ABY87540.1; -; Genomic_DNA.
DR   EMBL; AL022328; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471138; EAW73524.1; -; Genomic_DNA.
DR   EMBL; BC027933; AAH27933.1; -; mRNA.
DR   IPI; IPI00019473; -.
DR   PIR; G02524; G02524.
DR   PIR; JC5529; JC5529.
DR   RefSeq; NP_002742.3; -.
DR   UniGene; Hs.57732; -.
DR   PDB; 3GC8; X-ray; 2.40 A; A/B=1-364.
DR   PDB; 3GC9; X-ray; 2.05 A; A/B=1-364.
DR   PDB; 3GP0; X-ray; 1.90 A; A=5-350.
DR   PDBsum; 3GC8; -.
DR   PDBsum; 3GC9; -.
DR   PDBsum; 3GP0; -.
DR   ProteinModelPortal; Q15759; -.
DR   IntAct; Q15759; 8.
DR   MINT; MINT-3032032; -.
DR   STRING; Q15759; -.
DR   PhosphoSite; Q15759; -.
DR   PRIDE; Q15759; -.
DR   Ensembl; ENST00000330651; ENSP00000333685; ENSG00000185386.
DR   Ensembl; ENST00000395764; ENSP00000379113; ENSG00000185386.
DR   GeneID; 5600; -.
DR   KEGG; hsa:5600; -.
DR   UCSC; uc003bkr.1; human.
DR   CTD; 5600; -.
DR   GeneCards; GC22M050702; -.
DR   H-InvDB; HIX0203184; -.
DR   HGNC; HGNC:6873; MAPK11.
DR   HPA; CAB012961; -.
DR   MIM; 602898; gene.
DR   PharmGKB; PA30618; -.
DR   eggNOG; prNOG13362; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q15759; -.
DR   OMA; GTHEIEQ; -.
DR   OrthoDB; EOG94F8VP; -.
DR   PhylomeDB; Q15759; -.
DR   BRENDA; 2.7.11.24; 247.
DR   Pathway_Interaction_DB; il2_1pathway; IL2-mediated signaling events.
DR   Pathway_Interaction_DB; il6_7pathway; IL6-mediated signaling events.
DR   Pathway_Interaction_DB; p38_mkk3_6pathway; p38 MAPK signaling pathway.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; er_nongenomic_pathway; Plasma membrane estrogen receptor signaling.
DR   Pathway_Interaction_DB; p38alphabetapathway; Regulation of p38-alpha and p38-beta.
DR   Pathway_Interaction_DB; vegfr1_2_pathway; Signaling events mediated by VEGFR1 and VEGFR2.
DR   Pathway_Interaction_DB; p38alphabetadownstreampathway; Signaling mediated by p38-alpha and p38-beta.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Pathway_Interaction_DB; lymphangiogenesis_pathway; VEGFR3 signaling in lymphatic endothelium.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_21303; Myogenesis.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 21748; -.
DR   ArrayExpress; Q15759; -.
DR   Bgee; Q15759; -.
DR   CleanEx; HS_MAPK11; -.
DR   Genevestigator; Q15759; -.
DR   GermOnline; ENSG00000185386; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008339; F:MP kinase activity; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0007265; P:Ras protein signal transduction; EXP:Reactome.
DR   GO; GO:0006950; P:response to stress; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR008352; MAPK_p38.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01773; P38MAPKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    364       Mitogen-activated protein kinase 11.
FT                                /FTId=PRO_0000186280.
FT   DOMAIN       24    308       Protein kinase.
FT   NP_BIND      30     38       ATP (By similarity).
FT   MOTIF       180    182       TXY.
FT   ACT_SITE    150    150       Proton acceptor (By similarity).
FT   BINDING      53     53       ATP (By similarity).
FT   MOD_RES     180    180       Phosphothreonine (Probable).
FT   MOD_RES     182    182       Phosphotyrosine.
FT   VARIANT     221    221       A -> V (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_042264.
FT   VARIANT     275    275       R -> H (in dbSNP:rs33932986).
FT                                /FTId=VAR_025176.
FT   MUTAGEN     180    180       T->A: Inactivation.
FT   MUTAGEN     182    182       Y->F: Inactivation.
FT   CONFLICT    122    123       LS -> GAHQGARLAL (in Ref. 1; AAB05036).
FT   CONFLICT    326    326       S -> G (in Ref. 6; AAB66313).
FT   STRAND        9     15
FT   STRAND       17     20
FT   STRAND       27     29
FT   STRAND       38     43
FT   TURN         44     47
FT   STRAND       48     54
FT   HELIX        62     77
FT   HELIX        96     98
FT   STRAND      103    107
FT   HELIX       113    119
FT   HELIX       124    135
FT   HELIX       139    143
FT   HELIX       153    155
FT   STRAND      156    158
FT   STRAND      164    166
FT   HELIX       185    188
FT   HELIX       191    194
FT   HELIX       203    208
FT   HELIX       212    217
FT   HELIX       228    238
FT   HELIX       244    249
FT   TURN        253    255
FT   HELIX       256    260
FT   HELIX       270    273
FT   HELIX       279    284
FT   HELIX       293    295
FT   HELIX       299    302
FT   HELIX       306    308
FT   TURN        309    311
FT   HELIX       314    316
FT   HELIX       326    329
FT   HELIX       334    347
SQ   SEQUENCE   364 AA;  41357 MW;  68DA4C7B7C721475 CRC64;
     MSGPRAGFYR QELNKTVWEV PQRLQGLRPV GSGAYGSVCS AYDARLRQKV AVKKLSRPFQ
     SLIHARRTYR ELRLLKHLKH ENVIGLLDVF TPATSIEDFS EVYLVTTLMG ADLNNIVKCQ
     ALSDEHVQFL VYQLLRGLKY IHSAGIIHRD LKPSNVAVNE DCELRILDFG LARQADEEMT
     GYVATRWYRA PEIMLNWMHY NQTVDIWSVG CIMAELLQGK ALFPGSDYID QLKRIMEVVG
     TPSPEVLAKI SSEHARTYIQ SLPPMPQKDL SSIFRGANPL AIDLLGRMLV LDSDQRVSAA
     EALAHAYFSQ YHDPEDEPEA EPYDESVEAK ERTLEEWKEL TYQEVLSFKP PEPPKPPGSL
     EIEQ
//
